• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂(II)、钌(III)和铜(II)配合物的抗肿瘤活性。

Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.

机构信息

Institute of Biology, Jan Kochanowski University, Uniwersytecka 7, 25-406 Kielce, Poland.

Department of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego 63-77, 51-148 Wrocław, Poland.

出版信息

Molecules. 2020 Jul 31;25(15):3492. doi: 10.3390/molecules25153492.

DOI:10.3390/molecules25153492
PMID:32751963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7435640/
Abstract

Metal complexes are currently potential therapeutic compounds. The acquisition of resistance by cancer cells or the effective elimination of cancer-affected cells necessitates a constant search for chemical compounds with specific biological activities. One alternative option is the transition metal complexes having potential as antitumor agents. Here, we present the current knowledge about the application of transition metal complexes bearing nickel(II), cobalt(II), copper(II), ruthenium(III), and ruthenium(IV). The cytotoxic properties of the above complexes causing apoptosis, autophagy, DNA damage, and cell cycle inhibition are described in this review.

摘要

金属配合物是目前有潜力的治疗化合物。为了使癌细胞产生耐药性或有效消除受癌细胞影响的细胞,需要不断寻找具有特定生物活性的化合物。一种替代选择是具有抗肿瘤作用的过渡金属配合物。在这里,我们介绍了目前关于含镍(II)、钴(II)、铜(II)、钌(III)和钌(IV)的过渡金属配合物的应用知识。本综述描述了上述配合物通过诱导细胞凋亡、自噬、DNA 损伤和细胞周期抑制产生细胞毒性的特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/0969b39310f1/molecules-25-03492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/2a94095fd722/molecules-25-03492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/34722c3f2b68/molecules-25-03492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/71c99f4fe349/molecules-25-03492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/0969b39310f1/molecules-25-03492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/2a94095fd722/molecules-25-03492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/34722c3f2b68/molecules-25-03492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/71c99f4fe349/molecules-25-03492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/7435640/0969b39310f1/molecules-25-03492-g004.jpg

相似文献

1
Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.铂(II)、钌(III)和铜(II)配合物的抗肿瘤活性。
Molecules. 2020 Jul 31;25(15):3492. doi: 10.3390/molecules25153492.
2
Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.钌(II)和铂(II)配合物与具有生物活性的氨基黄酮配体表现出体外抗癌活性。
Int J Mol Sci. 2021 Jul 15;22(14):7568. doi: 10.3390/ijms22147568.
3
Novel metals and metal complexes as platforms for cancer therapy.新型金属和金属配合物作为癌症治疗的平台。
Curr Pharm Des. 2010 Jun;16(16):1813-25. doi: 10.2174/138161210791209009.
4
A New Photoactivatable Ruthenium(II) Complex with an Asymmetric Bis-Thiocarbohydrazone: Chemical and Biological Investigations.一种新型光活化钌(II)配合物,具有不对称双硫代卡巴肼:化学和生物学研究。
Molecules. 2021 Feb 10;26(4):939. doi: 10.3390/molecules26040939.
5
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.钌配合物的DNA结合模式及其与肿瘤细胞毒性的关系。
Drug Resist Updat. 2006 Jun;9(3):111-22. doi: 10.1016/j.drup.2006.05.002. Epub 2006 Jun 21.
6
Novel polypyridyl ruthenium complexes acting as high affinity DNA intercalators, potent transcription inhibitors and antitumor reagents.新型多吡啶钌配合物作为高亲和性 DNA 嵌入剂、强效转录抑制剂和抗肿瘤试剂。
J Inorg Biochem. 2018 Aug;185:1-9. doi: 10.1016/j.jinorgbio.2018.04.019. Epub 2018 May 2.
7
Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).抗氧化剂、体外、体内抗炎活性和消炎痛及其与锰(II)、钴(II)、镍(II)、铜(II)和锌(II)的金属配合物的增殖活性。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):742-52. doi: 10.1080/14756360802361589.
8
Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.中子活化可增强钌基配合物的活性,并在不依赖p53肿瘤抑制基因的情况下诱导胶质瘤细胞死亡。
Biometals. 2017 Apr;30(2):295-305. doi: 10.1007/s10534-017-0006-1. Epub 2017 Mar 3.
9
Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity.胡桃醌的铜(II)、钴(II)和镍(II)配合物:合成、结构、与DNA的相互作用及增强的细胞毒性
Biometals. 2016 Dec;29(6):981-993. doi: 10.1007/s10534-016-9970-0. Epub 2016 Sep 9.
10
An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy.评价铜(II)、铂(II)、钯(II)和钌(III)的复杂化合物在癌症治疗中的抗氧化和抗癌特性。
Mini Rev Med Chem. 2018;18(16):1373-1381. doi: 10.2174/1389557518666180423145825.

引用本文的文献

1
Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape.铜死亡作为癌症治疗靶点:研究现状的系统评价与文献计量分析
Front Oncol. 2025 May 16;15:1566986. doi: 10.3389/fonc.2025.1566986. eCollection 2025.
2
Apoptotic cell death induced by copper (II), manganese (II) and silver (I) complexes containing bridging dicarboxylate and 1,10-phenanthroline ligands: one of the multi-modes of anticancer activity?含桥联二羧酸酯和1,10-菲咯啉配体的铜(II)、锰(II)和银(I)配合物诱导的凋亡性细胞死亡:抗癌活性的多种模式之一?
Biometals. 2025 Mar 17. doi: 10.1007/s10534-025-00676-8.
3

本文引用的文献

1
Selective cytotoxicity and antifungal properties of copper(II) and cobalt(II) complexes with imidazole-4-acetate anion or 1-allylimidazole.咪唑-4-乙酸根或 1-烯丙基咪唑铜(II)和钴(II)配合物的选择性细胞毒性和抗真菌性质。
Sci Rep. 2019 Jul 5;9(1):9777. doi: 10.1038/s41598-019-46224-6.
2
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.3-(二丙基氨基)-5-羟基苯并呋喃[2,3-f]喹唑啉-1(2H)-酮(DPA-HBFQ-1)对乳腺癌细胞的生长和进展起抑制作用。
Eur J Med Chem. 2016 Jan 1;107:275-87. doi: 10.1016/j.ejmech.2015.11.004. Epub 2015 Nov 10.
3
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents.
氟喹诺酮衍生物类抗癌药物的最新研究进展。
Molecules. 2024 Jul 27;29(15):3538. doi: 10.3390/molecules29153538.
4
Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.铁和铜:铁死亡、铜死亡和其他细胞死亡形式的关键执行者。
Cell Commun Signal. 2023 Nov 16;21(1):327. doi: 10.1186/s12964-023-01267-1.
5
Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.水杨酸邻菲啰啉铜(II)配合物诱导结直肠癌细胞凋亡,包括奥沙利铂耐药细胞。
Oncol Rep. 2023 Sep;50(3). doi: 10.3892/or.2023.8607. Epub 2023 Jul 28.
6
Copper metabolism and hepatocellular carcinoma: current insights.铜代谢与肝细胞癌:当前见解
Front Oncol. 2023 Jul 5;13:1186659. doi: 10.3389/fonc.2023.1186659. eCollection 2023.
7
Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2--(2-quinolylmethylene)aminophenol.5-氯-2-[(2-喹啉基)亚甲基]氨基苯酚与 Cu(II)、Zn(II)和 Mn(II)配合物的抗癌活性及作用模式。
Molecules. 2023 Jun 20;28(12):4876. doi: 10.3390/molecules28124876.
8
Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.CORMs 的困境:四种市售 CO 释放分子(CORM-2、CORM-3、CORM-A1 和 CORM-401)在研究 CO 生物学中的不可靠性。
Biochem Pharmacol. 2023 Aug;214:115642. doi: 10.1016/j.bcp.2023.115642. Epub 2023 Jun 13.
9
Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer.构建铜死亡相关基因签名预测胃癌预后。
Biochem Genet. 2024 Feb;62(1):40-58. doi: 10.1007/s10528-023-10406-9. Epub 2023 May 27.
10
New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders.具有多种心血管疾病联合作用的新型亚硝酰钌配合物。
Dalton Trans. 2023 Apr 25;52(16):5176-5191. doi: 10.1039/d3dt00059a.
Advances in cobalt complexes as anticancer agents.
钴配合物作为抗癌剂的研究进展。
Dalton Trans. 2015 Aug 21;44(31):13796-808. doi: 10.1039/c5dt02101d.
4
Metal complex interactions with DNA.金属配合物与DNA的相互作用。
Dalton Trans. 2015 Feb 28;44(8):3505-26. doi: 10.1039/c4dt02700k.
5
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.金属组学研究揭示了基于金属的抗癌化合物诱导程序性细胞死亡的机制。
Metallomics. 2014 May;6(5):978-95. doi: 10.1039/c3mt00225j.
6
Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.选择性抗癌铜(II)混合配体配合物:靶向活性氧和蛋白酶体。
Metallomics. 2014 Apr;6(4):892-906. doi: 10.1039/c3mt00276d.
7
Nickel(II), copper(II) and zinc(II) metallo-intercalators: structural details of the DNA-binding by a combined experimental and computational investigation.镍(II)、铜(II)和锌(II)金属嵌入剂:通过实验与计算相结合的研究对DNA结合的结构细节
Dalton Trans. 2014 Apr 28;43(16):6108-19. doi: 10.1039/c3dt53066c.
8
Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.钌-芳烃-β-咔啉配合物作为细胞周期蛋白依赖性激酶1的有效抑制剂:合成、表征及抗癌机制研究
Chemistry. 2013 Sep 2;19(36):12152-60. doi: 10.1002/chem.201301389. Epub 2013 Jul 22.
9
Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.组蛋白去乙酰化酶靶向荧光钌(II)多吡啶配合物作为有效的抗癌药物。
Chemistry. 2013 Jul 29;19(31):10160-9. doi: 10.1002/chem.201300814. Epub 2013 Jul 4.
10
Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione.通过铜螯合物N-(2-羟基苯乙酮)甘氨酸铜,无论药物敏感性如何,在各种癌细胞中选择性诱导凋亡:谷胱甘肽的关键作用
Biometals. 2013 Jun;26(3):517-34. doi: 10.1007/s10534-013-9637-z. Epub 2013 Jun 4.